| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 7,100 |
-
| 103 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 7,100 |
-
| 103 | | | Operating Expenses | | Research Development | 23,607 | 20,818 | 15,219 | | Selling General and Administrative | 8,696 | 8,496 | 11,860 | | Non Recurring | 2,639 |
-
| 450 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (27,842) | (29,314) | (27,426) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,036 | 4,638 | 3,637 | | Earnings Before Interest And Taxes | (24,806) | (24,676) | (23,789) | | Interest Expense | 293 | 488 | 467 | | Income Before Tax | (25,099) | (25,164) | (24,256) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (25,099) | (25,164) | (24,256) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (25,099) | (25,164) | (24,256) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($25,099) | ($25,164) | ($24,256) |
|
0.29% Nasdaq 
0.08 (5.26%) 
Income Statement
